Fort Point Capital Partners LLC Q2 2019 Filing

Filed August 9, 2019

Portfolio Value

$253.2B

Holdings

101

Report Date

Q2 2019

Filing Type

13F-HR

All Holdings (101 positions)

#StockSharesValue% PortfolioType
101
RIGLUSDRIGEL PHARMACEUTICALS INC
17,000$44.0M0.02%
PreviousPage 2 of 2